Literature DB >> 7011990

Protective effect of immunization of rats with holotoxin or B subunit of Escherichia coli heat-labile enterotoxin.

F A Klipstein, R F Engert.   

Abstract

The relative immunogenicities of three forms of the Escherichia coli heatlabile enterotoxin (LT), the holotoxin, its B subunit, and the polymyxin-release form (PM LT) were compared by immunizing rats with various dosages of each given exclusively by the parenteral (IP/IP) or peroral (PO/PO) routes or by a combination of the two (IP/PO). The degree of protection was evaluated by challenge in ligated ileal loops, and the serum antitoxin response was determined by an enzyme-linked immunosorbent assay with homologous antigens. When given by the PO/PO route, each LT antigen provided only weak protection against the toxin and virtually none against viable LT-producing strains; serum antitoxin titers were not significantly increased. When the toxins were given after a parental primary immunization by either the IP/IP or the IP/PO routes, each LT antigen provided a dose-related increase in serum antitoxin titers and in the degree of protection against the toxin as well as against viable strains which produce LT alone (LT(+)/ST(-)) or in combination with the heat-stable toxin (LT(+)/ST(+)). The degree of protection against viable bacteria, particularly the LT(+)/ST(+) strain, was stronger in animals which received booster immunizations by the PO route. When expressed on the basis of molar equivalents, holotoxin provided significant protection (a protection index of >5 against toxin challenge and >50% reduced secretion with bacterial challenge) with 4 to 15 times fewer moles than PM LT and up to 50 times fewer moles than the B subunit. These observations indicate that, on the basis of molar equivalents, the holotoxin (which contains one A plus five or six B subunits) is a more potent immunogen than either PM LT (which contains one A and probably one B subunit) or the B subunit.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7011990      PMCID: PMC351763          DOI: 10.1128/iai.31.1.144-150.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  The molecular nature of heat-labile enterotoxin (LT) of escherichia coli.

Authors:  W S Dallas; S Falkow
Journal:  Nature       Date:  1979-02-01       Impact factor: 49.962

2.  Protection against experimental cholera by antitoxin.

Authors:  N F Pierce; E A Kaniecki; R S Northrup
Journal:  J Infect Dis       Date:  1972-12       Impact factor: 5.226

3.  Properties of homogeneous heat-labile enterotoxin from Escherichia coli.

Authors:  J D Clements; R J Yancey; R A Finkelstein
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

4.  Antitoxic immunity in experimental cholera: protection, and serum and local antibody responses in rabbits after enteral and parenteral immunization.

Authors:  J Holmgren; A M Svennerholm; O Ouchterlony; A Anderson; G Walletström; U Westerberg-Berndtsson
Journal:  Infect Immun       Date:  1975-12       Impact factor: 3.441

5.  Adenosine diphosphate-ribosylation of adenylate cyclase catalyzed by heat-labile enterotoxin of Escherichia coli: comparison with cholera toxin.

Authors:  D M Gill; S H Richardson
Journal:  J Infect Dis       Date:  1980-01       Impact factor: 5.226

6.  Protection against challenge with Escherichia coli heat-labile enterotoxin by immunization of rats with cholera toxin/toxoid.

Authors:  N F Pierce
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

7.  Immunological control mechanism against cholera toxin: interference with toxin binding to intestinal receptors.

Authors:  A L Wu; W A Walker
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

8.  Antitoxic immunity to cholera in dogs immunized orally with cholera toxin.

Authors:  N F Pierce; W C Cray; P F Engel
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

9.  Polymyxin B-Induced Release of Low-Molecular-Weight, Heat-Labile Enterotoxin from Escherichia coli.

Authors:  D J Evans; D G Evans; S L Gorbach
Journal:  Infect Immun       Date:  1974-11       Impact factor: 3.441

10.  Cellular kinetics of the intestinal immune response to cholera toxoid in rats.

Authors:  N F Pierce; J L Gowans
Journal:  J Exp Med       Date:  1975-12-01       Impact factor: 14.307

View more
  13 in total

1.  Peroral immunization of rats with Escherichia coli heat-labile enterotoxin delivered by microspheres.

Authors:  F A Klipstein; R F Engert; W T Sherman
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

Review 2.  New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.

Authors:  M M Levine; J B Kaper; R E Black; M L Clements
Journal:  Microbiol Rev       Date:  1983-12

3.  Local and systemic immune response to orally administered liposome-associated soluble S. mutans cell wall antigens.

Authors:  D Wachsmann; J P Klein; M Schöller; R M Frank
Journal:  Immunology       Date:  1985-01       Impact factor: 7.397

4.  Properties of synthetically produced Escherichia coli heat-stable enterotoxin.

Authors:  F A Klipstein; R F Engert; R A Houghten
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

5.  Effect of parenteral immunization on the local immunoglobulin A response of the intestine to Shigella flexneri antigens.

Authors:  D F Keren; P J Scott; R A McDonald; M Wiatrak
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

6.  Development of a vaccine of cross-linked heat-stable and heat-labile enterotoxins that protects against Escherichia coli producing either enterotoxin.

Authors:  F A Klipstein; R F Engert; J D Clements
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

7.  Protection against human and porcine enterotoxigenic strains of Escherichia coli in rats immunized with a cross-linked toxoid vaccine.

Authors:  F A Klipstein; R F Engert; J D Clements; R A Houghten
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

8.  Properties of crude Campylobacter jejuni heat-labile enterotoxin.

Authors:  F A Klipstein; R F Engert
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

9.  Protection in rabbits immunized with a vaccine of Escherichia coli heat-stable toxin cross-linked to the heat-labile toxin B subunit.

Authors:  F A Klipstein; R F Engert; R A Houghten
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

10.  Differences in cross-protection in rats immunized with the B subunits of cholera toxin and Escherichia coli heat-labile toxin.

Authors:  F A Klipstein; R F Engert; J D Clements; R A Houghten
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.